{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T06:06:57Z","timestamp":1788934017423,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"PRIN from MIUR, Italy","award":["Grant 2020KSY3KL_005"],"award-info":[{"award-number":["Grant 2020KSY3KL_005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Microbiol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00284-026-04936-9","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T11:09:54Z","timestamp":1777633794000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["HIV-1 and Vaccine: Analysis of gp41 Target Sequences"],"prefix":"10.1007","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1424-8931","authenticated-orcid":false,"given":"Salvatore","family":"Dimonte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossana","family":"Scutari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"Salpini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Aquaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Svicher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Pellegrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,1]]},"reference":[{"key":"4936_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/imr.12507","volume":"275","author":"AB Ward","year":"2017","unstructured":"Ward AB, Wilson IA (2017) The HIV-1 envelope glycoprotein structure: nailing down a moving target. Immunol Rev 275:21\u201332. https:\/\/doi.org\/10.1111\/imr.12507","journal-title":"Immunol Rev"},{"key":"4936_CR2","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.immuni.2011.01.015","volume":"34","author":"M Bomsel","year":"2011","unstructured":"Bomsel M, Tudor D, Drillet AS et al (2011) Immunization with HIV-1 Gp41 subunit virosomes induces mucosal antibodies protecting nonhuman primates against vaginal SHIV challenges. Immunity 34:269\u2013280. https:\/\/doi.org\/10.1016\/j.immuni.2011.01.015","journal-title":"Immunity"},{"issue":"6623","key":"4936_CR3","doi-asserted-by":"publisher","DOI":"10.1126\/science.add6502","volume":"378","author":"DJ Leggat","year":"2022","unstructured":"Leggat DJ, Cohen KW, Willis JR et al (2022) Vaccination induces HIV broadly neutralizing antibody precursors in humans. Science 378(6623):eadd6502. https:\/\/doi.org\/10.1126\/science.add6502","journal-title":"Science"},{"key":"4936_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1075606","volume":"13","author":"A Horvath","year":"2023","unstructured":"Horvath A, Rogers L, Pollakis G et al (2023) Systematic comparison of HIV-1 envelope-specific IgG responses induced by different vaccination regimens: can we steer IgG recognition towards regions of viral vulnerability? Front Immunol 13:1075606. https:\/\/doi.org\/10.3389\/fimmu.2022.1075606","journal-title":"Front Immunol"},{"issue":"1","key":"4936_CR5","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3390\/vaccines8010054","volume":"8","author":"R Chapman","year":"2020","unstructured":"Chapman R, van Diepen M, Galant S et al (2020) Immunogenicity of HIV-1 vaccines expressing chimeric envelope glycoproteins on the surface of Pr55 Gag virus-like particles. Vaccines (Basel) 8(1):54. https:\/\/doi.org\/10.3390\/vaccines8010054","journal-title":"Vaccines (Basel)"},{"key":"4936_CR6","doi-asserted-by":"publisher","first-page":"283","DOI":"10.2174\/1570162x14999160224103908","volume":"14","author":"HA Yi","year":"2016","unstructured":"Yi HA, Fochtman BC, Rizzo RC, Jacobs A (2016) Inhibition of HIV entry by targeting the envelope transmembrane subunit Gp41. Curr HIV Res 14:283\u2013294. https:\/\/doi.org\/10.2174\/1570162x14999160224103908","journal-title":"Curr HIV Res"},{"key":"4936_CR7","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00142-19","volume":"93","author":"M Zhuang","year":"2019","unstructured":"Zhuang M, Vassell R, Yuan C et al (2019) Mutations that increase the stability of the postfusion Gp41 conformation of the HIV-1 envelope glycoprotein are selected by both an X4 and R5 HIV-1 virus to escape fusion inhibitors corresponding to heptad repeat 1 of Gp41, but the Gp120 adaptive mutations differ between the two viruses. J Virol 93:e00142-19. https:\/\/doi.org\/10.1128\/jvi.00142-19","journal-title":"J Virol"},{"issue":"1","key":"4936_CR8","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.03134-20","volume":"12","author":"Y Hikichi","year":"2021","unstructured":"Hikichi Y, Van Duyne R, Pham P et al (2021) Mechanistic analysis of the broad antiretroviral resistance conferred by HIV-1 envelope glycoprotein mutations. MBio 12(1):e03134-20. https:\/\/doi.org\/10.1128\/mbio.03134-20","journal-title":"MBio"},{"key":"4936_CR9","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1007\/s15010-013-0464-5","volume":"41","author":"S Dimonte","year":"2013","unstructured":"Dimonte S, Babakir-Mina M, Aquaro S, Perno CF (2013) Natural polymorphisms of HIV-1 subtype-C integrase coding region in a large group of ARV-na\u00efve infected individuals. Infection 41:1097\u20131102. https:\/\/doi.org\/10.1007\/s15010-013-0464-5","journal-title":"Infection"},{"key":"4936_CR10","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/jmv.24611","volume":"89","author":"S Dimonte","year":"2017","unstructured":"Dimonte S (2017) Different HIV-1 env frames: Gp120 and ASP (antisense protein) biosynthesis, and theirs co-variation tropic amino acid signatures in X4- and R5-viruses. J Med Virol 89:112\u2013122. https:\/\/doi.org\/10.1002\/jmv.24611","journal-title":"J Med Virol"},{"key":"4936_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068188","volume":"8","author":"GK Hightower","year":"2013","unstructured":"Hightower GK, May SJ, P\u00e9rez-Santiago J et al (2013) HIV-1 clade B pol evolution following primary infection. PLoS ONE 8:e68188. https:\/\/doi.org\/10.1371\/journal.pone.0068188","journal-title":"PLoS ONE"},{"key":"4936_CR12","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1093\/oxfordjournals.molbev.a040317","volume":"1","author":"F Tajima","year":"1984","unstructured":"Tajima F, Nei M (1984) Estimation of evolutionary distance between nucleotide sequences. Mol Biol Evol 1:269\u2013285. https:\/\/doi.org\/10.1093\/oxfordjournals.molbev.a040317","journal-title":"Mol Biol Evol"},{"key":"4936_CR13","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1093\/oxfordjournals.molbev.a040410","volume":"3","author":"M Nei","year":"1986","unstructured":"Nei M, Gojobori T (1986) Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol Biol Evol 3:418\u2013426. https:\/\/doi.org\/10.1093\/oxfordjournals.molbev.a040410","journal-title":"Mol Biol Evol"},{"key":"4936_CR14","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1093\/molbev\/msw054","volume":"33","author":"S Kumar","year":"2016","unstructured":"Kumar S, Stecher G, Tamura K (2016) MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets. Mol Biol Evol 33:1870\u20131874. https:\/\/doi.org\/10.1093\/molbev\/msw054","journal-title":"Mol Biol Evol"},{"key":"4936_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007388","volume":"4","author":"OO Yang","year":"2009","unstructured":"Yang OO (2009) Candidate vaccine sequences to represent intra- and inter-clade HIV-1 variation. PLoS ONE 4:e7388. https:\/\/doi.org\/10.1371\/journal.pone.0007388","journal-title":"PLoS ONE"},{"key":"4936_CR16","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate-a practical and powerful approach to multiple testing. J R Stat Soc Ser A Gen 57:289\u2013300","journal-title":"J R Stat Soc Ser A Gen"},{"key":"4936_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1000304","volume":"4","author":"S Kryazhimskiy","year":"2008","unstructured":"Kryazhimskiy S, Plotkin JB (2008) The population genetics of dN\/dS. PLoS Genet 4:e1000304. https:\/\/doi.org\/10.1371\/journal.pgen.1000304","journal-title":"PLoS Genet"},{"key":"4936_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-8-33","volume":"8","author":"S Dimonte","year":"2011","unstructured":"Dimonte S, Mercurio F, Svicher V et al (2011) Selected amino acid mutations in HIV-1 B subtype Gp41 are associated with specific Gp120V3 signatures in the regulation of co-receptor usage. Retrovirology 8:33. https:\/\/doi.org\/10.1186\/1742-4690-8-33","journal-title":"Retrovirology"},{"key":"4936_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/nmicrobiol.2016.199","volume":"2","author":"MJ van Gils","year":"2016","unstructured":"van Gils MJ, van den Kerkhof TL, Ozorowski G et al (2016) An HIV-1 antibody from an elite neutralizer implicates the fusion peptide as a site of vulnerability. Nat Microbiol 2:16199. https:\/\/doi.org\/10.1038\/nmicrobiol.2016.199","journal-title":"Nat Microbiol"},{"key":"4936_CR20","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1128\/mmbr.00020-07","volume":"72","author":"M Montero","year":"2008","unstructured":"Montero M, van Houten NE, Wang X, Scott JK (2008) The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: dominant site of antibody neutralization and target for vaccine design. Microbiol Mol Biol Rev 72:54\u201384. https:\/\/doi.org\/10.1128\/mmbr.00020-07","journal-title":"Microbiol Mol Biol Rev"},{"key":"4936_CR21","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1097\/qad.0b013e328329f97d","volume":"23","author":"O Lambotte","year":"2009","unstructured":"Lambotte O, Ferrari G, Moog C, Yates NL, Liao HX, Parks RJ, Hicks CB, Owzar K, Tomaras GD, Montefiori DC, Haynes BF, Delfraissy JF (2009) Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers. AIDS 23:897\u2013906. https:\/\/doi.org\/10.1097\/qad.0b013e328329f97d","journal-title":"AIDS"},{"key":"4936_CR22","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1126\/science.1178746","volume":"326","author":"LM Walker","year":"2009","unstructured":"Walker LM et al (2009) Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target. Science 326:285\u2013289. https:\/\/doi.org\/10.1126\/science.1178746","journal-title":"Science"},{"key":"4936_CR23","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s12250-016-3820-7","volume":"31","author":"X Zhang","year":"2016","unstructured":"Zhang X, Zhang F, Ma X et al (2016) Identification of interaction between HIV-1 glycoprotein 41 and integrase. Virol Sin 31:415\u2013424. https:\/\/doi.org\/10.1007\/s12250-016-3820-7","journal-title":"Virol Sin"},{"key":"4936_CR24","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01779-17","volume":"92","author":"ZM Qualls","year":"2018","unstructured":"Qualls ZM, Choudhary A, Honnen W et al (2018) Identification of novel structural determinants in MW965 Env that regulate the neutralization phenotype and conformational masking potential of primary HIV-1 isolates. J Virol 92:e01779-17. https:\/\/doi.org\/10.1128\/jvi.01779-17","journal-title":"J Virol"},{"key":"4936_CR25","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1128\/jvi.02053-12","volume":"87","author":"TS Postler","year":"2013","unstructured":"Postler TS, Desrosiers RC (2013) The tale of the long tail: the cytoplasmic domain of HIV-1 Gp41. J Virol 87:2\u201315. https:\/\/doi.org\/10.1128\/jvi.02053-12","journal-title":"J Virol"},{"key":"4936_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-10-54","volume":"10","author":"E Santos da Silva","year":"2013","unstructured":"Santos da Silva E, Mulinge M, Perez BD (2013) The frantic play of the concealed HIV envelope cytoplasmic tail. Retrovirology 10:54. https:\/\/doi.org\/10.1186\/1742-4690-10-54","journal-title":"Retrovirology"},{"key":"4936_CR27","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00876-22","volume":"96","author":"MV Fernandez-de C\u00e9spedes","year":"2022","unstructured":"Fernandez-de C\u00e9spedes MV, Hoffman HK, Carter H et al (2022) Rab11-FIP1C is dispensable for HIV-1 replication in primary CD4+ T cells, but its role is cell type dependent in immortalized human T-cell lines. J Virol 96:e0087622. https:\/\/doi.org\/10.1128\/jvi.00876-22","journal-title":"J Virol"},{"key":"4936_CR28","doi-asserted-by":"publisher","first-page":"43","DOI":"10.12932\/ap-101017-0177","volume":"37","author":"S Sangjan","year":"2019","unstructured":"Sangjan S, Ampol S, Tabprasit S et al (2019) Common antibody dependent cell mediated cytotoxicity (ADCC) antibody epitopes of HIV-1 CRF01_AE Env and Gag in early HIV-1 infected individuals. Asian Pac J Allergy Immunol 37:43\u201350. https:\/\/doi.org\/10.12932\/ap-101017-0177","journal-title":"Asian Pac J Allergy Immunol"},{"key":"4936_CR29","doi-asserted-by":"publisher","first-page":"5344","DOI":"10.1016\/j.vaccine.2016.08.089","volume":"34","author":"AC Andersson","year":"2016","unstructured":"Andersson AC, Ragonnaud E, Seaton KE et al (2016) Effect of HIV-1 envelope cytoplasmic tail on adenovirus primed virus encoded virus-like particle immunizations. Vaccine 34:5344\u20135351. https:\/\/doi.org\/10.1016\/j.vaccine.2016.08.089","journal-title":"Vaccine"},{"key":"4936_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-10-14","volume":"10","author":"W Wang","year":"2013","unstructured":"Wang W, Nie J, Prochnow C, Truong C, Jia Z, Wang S, Chen XS, Wang Y (2013) A systematic study of the N-glycosylation sites of HIV-1 envelope protein on infectivity and antibody-mediated neutralization. Retrovirology 10:14. https:\/\/doi.org\/10.1186\/1742-4690-10-14","journal-title":"Retrovirology"}],"updated-by":[{"DOI":"10.1007\/s00284-026-05045-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000}}],"container-title":["Current Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-026-04936-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00284-026-04936-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-026-04936-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:39:22Z","timestamp":1788932362000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00284-026-04936-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["4936"],"URL":"https:\/\/doi.org\/10.1007\/s00284-026-04936-9","relation":{},"ISSN":["0343-8651","1432-0991"],"issn-type":[{"value":"0343-8651","type":"print"},{"value":"1432-0991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]},"assertion":[{"value":"19 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All the authors\u2019 givenname and family name are inverted by mistakenly. The authors\u2019 given name and family name are corrected from \u201cDimonte Salvatore, Scutari Rossana, Salpini Romina, Aquaro Stefano, Svicher Valentina, Pellegrino Michele\u201d to \u201cSalvatore Dimonte, Rossana Scutari, Romina Salpini, Stefano Aquaro, Valentina Svicher, Michele Pellegrino\u201d.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2026","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00284-026-05045-3","URL":"https:\/\/doi.org\/10.1007\/s00284-026-05045-3","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"343"}}